Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Kogo (Kyoto, Japan), S. Sato (Kyoto, Japan), S. Muro (Nara, Japan), N. Nomura (Kyoto, Japan), N. Tashima (Kyoto, Japan), T. Oguma (Kyoto, Japan), K. Murase (Kyoto, Japan), T. Kawaguchi (Kyoto, Japan), Y. Tabara (Kyoto, Japan), F. Matsuda (Kyoto, Japan), K. Chin (Kyoto, Japan), T. Hirai (Kyoto, Japan), H. Matsumoto (Kyoto, Japan). The association between airflow limitation and dyspnea and comorbidity related to COPD in the Nagahama study. 1438

Member's Comments

No comment yet.

Related content which might interest you: Airflow limitation or dynamic hyperinflation, which is more closely related to dyspnoea in patients with COPD? Source: Annual Congress 2009 - Quality of life and symptoms in COPD Year: 2009 Impact of age-related comorbidities on the risk of COPD exacerbations in subjects with severe airflow limitation: A pan-European study Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Respiratory symptoms, smoking history and airflow limitation: How should we define COPD? Source: Annual Congress 2011 - Respiratory epidemiology: methods, definitions and phenotypes Year: 2011 frequent exacerbations of COPD are associated with severity of airflow limitation and chronic cough, sputum production. Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 Relationship between symptoms and airflow limitation in COPD: in stable disease and during exacerbations Source: Eur Respir J 2002; 20: Suppl. 38, 250s Year: 2002 The derivation of a new index of severity for COPD patients, the DOSE index: MRC dyspnea scale, airflow obstruction, smoking status and exacerbations Source: Annual Congress 2007 - Predicting factors of patients undergoing rehabilitation Year: 2007 An observational study of age-related smoking status in COPD patients stratified by severity of airflow obstruction Source: International Congress 2015 – Management of asthma and COPD in primary care Year: 2015 Clinical characteristics of patients with clinically-diagnosed COPD exacerbations but without concomitant airflow limitation Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Does airflow limitation severity in stable condition severity of COPD influences in patient cardiac autonomic modulation in COPD patients during hospitalization for exacerbation? Source: Virtual Congress 2020 – COPD phenotypes Year: 2020 Reversibility of airflow limitation in elderly patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 336s Year: 2007 Characterization of COPD patients with severe airflow limitation and high physical activity Source: International Congress 2018 – Determinants of physical activity behaviour in patients with COPD and the physiotherapist as a physical activity coach Year: 2018 The importance of dyspnea and airflow limitation for anxiety and depression in COPD Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 Association between airflow limitation severity and comorbidities in Japanese men Source: Virtual Congress 2020 – Risk factors for chronic lung diseases Year: 2020 Impacts of bronchiectasis in asthma patients with airflow limitation Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020 Gender differences in dyspnea and its association with lung function in COPD and asthma Source: International Congress 2017 – Evaluating lung function, dyspnoea and related respiratory diseases Year: 2017 Symptom variability in patients with severe COPD: a pan-European cross-sectional study Source: Eur Respir J 2011; 37: 264 Year: 2011 A high degree of dyspnea is associated with poor exercise capacity in COPD patients, airflow obstruction being equal Source: International Congress 2018 – What’s new in lung function and exercise assessment in COPD? Year: 2018 Determinants for the reversibility of airflow limitation in COPD Source: Eur Respir J 2005; 26: Suppl. 49, 289s Year: 2005 Interpreting thresholds for a clinically significant change in health status in asthma and COPD Source: Eur Respir J 2002; 19: 398-404 Year: 2002 Prevalence, predictors and impact of nocturnal hypoxemia in non-apnoeic patients with COPD Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015